{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:35:47Z","timestamp":1761921347671,"version":"build-2065373602"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015650","name":"Canon Medical Systems Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JSTS.KAKEN; No. 20K08037"],"award-info":[{"award-number":["JSTS.KAKEN; No. 20K08037"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11653-7","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T05:44:55Z","timestamp":1747892695000},"page":"7167-7180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-1084","authenticated-orcid":false,"given":"Yoshiharu","family":"Ohno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirona","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruomi","family":"Akino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"11653_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"11653_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431\u2013440","journal-title":"Am J Respir Crit Care Med"},{"key":"11653_CR3","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"G Raghu","year":"2012","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366:1968\u20131977","journal-title":"N Engl J Med"},{"key":"11653_CR4","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez P\u00e9rez ER, Swigris JJ, Forss\u00e9n AV et al (2013) Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 144:1644\u20131651","DOI":"10.1378\/chest.12-2685"},{"key":"11653_CR5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B et al (2014) Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 145:723\u2013728","journal-title":"Chest"},{"key":"11653_CR6","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ et al (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655\u20132666","journal-title":"N Engl J Med"},{"key":"11653_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","volume":"151","author":"J Morisset","year":"2017","unstructured":"Morisset J, Johannson KA, Vittinghoff E et al (2017) Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest 151:619\u2013625","journal-title":"Chest"},{"key":"11653_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","volume":"4","author":"SLF Walsh","year":"2016","unstructured":"Walsh SLF, Wells AU, Desai SR et al (2016) Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 4:557\u2013565","journal-title":"Lancet Respir Med"},{"key":"11653_CR9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.201702-0400PP","volume":"196","author":"CJ Ryerson","year":"2017","unstructured":"Ryerson CJ, Corte TJ, Lee JS et al (2017) A standardized diagnostic ontology for fibrotic interstitial lung disease. An International Working Group perspective. Am J Respir Crit Care Med 196:1249\u20131254","journal-title":"Am J Respir Crit Care Med"},{"key":"11653_CR10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.2020201138","volume":"297","author":"H Hatabu","year":"2020","unstructured":"Hatabu H, Ohno Y, Gefter WB et al (2020) Expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: Fleischner Society position paper. Radiology 297:286\u2013301","journal-title":"Radiology"},{"key":"11653_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.2020203108","volume":"298","author":"M Remy-Jardin","year":"2021","unstructured":"Remy-Jardin M, Ryerson CJ, Schiebler ML et al (2021) Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Radiology 298:531\u2013549","journal-title":"Radiology"},{"key":"11653_CR12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1148\/radiol.2021203711","volume":"299","author":"Y Ohno","year":"2021","unstructured":"Ohno Y, Seo JB, Parraga G et al (2021) Pulmonary functional imaging: Part 1\u2014State-of-the-art technical and physiologic underpinnings. Radiology 299:508\u2013523","journal-title":"Radiology"},{"key":"11653_CR13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1148\/radiol.2021204033","volume":"299","author":"WB Gefter","year":"2021","unstructured":"Gefter WB, Lee KS, Schiebler ML et al (2021) Pulmonary functional imaging: Part 2\u2014State-of-the-art clinical applications and opportunities for improved patient care. Radiology 299:524\u2013538","journal-title":"Radiology"},{"key":"11653_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2463\/mrms.rev.2020-0184","volume":"21","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Ohno Y, Hanamatsu S et al (2022) State-of-the-art MR imaging for thoracic diseases. Magn Reson Med Sci 21:212\u2013234","journal-title":"Magn Reson Med Sci"},{"key":"11653_CR15","doi-asserted-by":"crossref","first-page":"20201053","DOI":"10.1259\/bjr.20201053","volume":"95","author":"Y Ohno","year":"2022","unstructured":"Ohno Y, Hanamatsu S, Obama Y et al (2022) Overview of MRI for pulmonary functional imaging. Br J Radiol 95:20201053","journal-title":"Br J Radiol"},{"key":"11653_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RLI.0000000000001017","volume":"59","author":"Y Ohno","year":"2024","unstructured":"Ohno Y, Ozawa Y, Nagata H et al (2024) Lung magnetic resonance imaging: technical advancements and clinical applications. Invest Radiol 59:38\u201352","journal-title":"Invest Radiol"},{"key":"11653_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1148\/radiol.10100245","volume":"258","author":"Y Ohno","year":"2011","unstructured":"Ohno Y, Koyama H, Matsumoto K et al (2011) Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET\/CT. Radiology 258:599\u2013609","journal-title":"Radiology"},{"key":"11653_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.14132289","volume":"274","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Nishio M, Koyama H et al (2015) Solitary pulmonary nodules: comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET\/CT. Radiology 274:563\u2013575","journal-title":"Radiology"},{"key":"11653_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejrad.2015.11.009","volume":"85","author":"Y Ohno","year":"2016","unstructured":"Ohno Y, Koyama H, Fujisawa Y et al (2016) Dynamic contrast-enhanced perfusion area detector CT for non-small cell lung cancer patients: influence of mathematical models on early prediction capabilities for treatment response and recurrence after chemoradiotherapy. Eur J Radiol 85:176\u2013186","journal-title":"Eur J Radiol"},{"key":"11653_CR20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejrad.2016.11.008","volume":"86","author":"Y Ohno","year":"2017","unstructured":"Ohno Y, Fujisawa Y, Koyama H et al (2017) Dynamic contrast-enhanced perfusion area-detector CT assessed with various mathematical models: its capability for therapeutic outcome prediction for non-small cell lung cancer patients with chemoradiotherapy as compared with that of FDG-PET\/CT. Eur J Radiol 86:83\u201391","journal-title":"Eur J Radiol"},{"key":"11653_CR21","doi-asserted-by":"crossref","first-page":"W253","DOI":"10.2214\/AJR.17.17959","volume":"209","author":"Y Ohno","year":"2017","unstructured":"Ohno Y, Fujisawa Y, Sugihara N et al (2017) Dynamic contrast-enhanced perfusion area-detector CT: preliminary comparison of diagnostic performance for N stage assessment with FDG PET\/CT in non-small cell lung cancer. AJR Am J Roentgenol 209:W253\u2013W262","journal-title":"AJR Am J Roentgenol"},{"key":"11653_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejrad.2019.03.018","volume":"115","author":"Y Ohno","year":"2019","unstructured":"Ohno Y, Fujisawa Y, Yui M et al (2019) Solitary pulmonary nodule: comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET\/CT. Eur J Radiol 115:22\u201330","journal-title":"Eur J Radiol"},{"key":"11653_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2463\/mrms.mp.2018-0158","volume":"19","author":"S Seki","year":"2020","unstructured":"Seki S, Fujisawa Y, Yui M et al (2020) Dynamic contrast-enhanced area-detector CT vs dynamic contrast-enhanced perfusion MRI vs FDG-PET\/CT: comparison of utility for quantitative therapeutic outcome prediction for NSCLC patients undergoing chemoradiotherapy. Magn Reson Med Sci 19:29\u201339","journal-title":"Magn Reson Med Sci"},{"key":"11653_CR24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718\u20131727","journal-title":"N Engl J Med"},{"key":"11653_CR25","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","volume":"35","author":"M Wijsenbeek","year":"2019","unstructured":"Wijsenbeek M, Kreuter M, Olson A et al (2019) Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin 35:2015\u20132024","journal-title":"Curr Med Res Opin"},{"key":"11653_CR26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Spagnolo P, Kreuter M et al (2020) Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med 8:925\u2013934","journal-title":"Lancet Respir Med"},{"key":"11653_CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A et al (2020) Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 8:147\u2013157","journal-title":"Lancet Respir Med"},{"key":"11653_CR28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","volume":"8","author":"AU Wells","year":"2020","unstructured":"Wells AU, Flaherty KR, Brown KK et al (2020) Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 8:453\u2013460","journal-title":"Lancet Respir Med"},{"key":"11653_CR29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, M\u00fcller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697\u2013722","journal-title":"Radiology"},{"key":"11653_CR30","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"key":"11653_CR31","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205:e18\u2013e47","journal-title":"Am J Respir Crit Care Med"},{"key":"11653_CR32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1378\/chest.06-1401","volume":"131","author":"G Camiciottoli","year":"2007","unstructured":"Camiciottoli G, Orlandi I, Bartolucci M et al (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 131:672\u2013681","journal-title":"Chest"},{"key":"11653_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jmri.21550","volume":"28","author":"Y Ohno","year":"2008","unstructured":"Ohno Y, Koyama H, Nogami M et al (2008) Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease. J Magn Reson Imaging 28:887\u2013899","journal-title":"J Magn Reson Imaging"},{"key":"11653_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejrad.2013.11.001","volume":"83","author":"Y Ohno","year":"2014","unstructured":"Ohno Y, Nishio M, Koyama H et al (2014) Oxygen-enhanced MRI for patients with connective tissue diseases: comparison with thin-section CT of capability for pulmonary functional and disease severity assessment. Eur J Radiol 83:391\u2013397","journal-title":"Eur J Radiol"},{"key":"11653_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307\u2013310","journal-title":"Lancet"},{"key":"11653_CR36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","volume":"99","author":"KR Stenmark","year":"2006","unstructured":"Stenmark KR, Fagan KA, Frid MG (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99:675\u2013691","journal-title":"Circ Res"},{"key":"11653_CR37","volume":"10","author":"Y Kinoshita","year":"2020","unstructured":"Kinoshita Y, Ishii H, Kushima H et al (2020) Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis. Sci Rep 10:306","journal-title":"Sci Rep"},{"key":"11653_CR38","doi-asserted-by":"crossref","first-page":"00571","DOI":"10.1183\/23120541.00571-2021","volume":"8","author":"AV Gaikwad","year":"2022","unstructured":"Gaikwad AV, Lu W, Dey S et al (2022) Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition. ERJ Open Res 8:00571\u20132021","journal-title":"ERJ Open Res"},{"key":"11653_CR39","doi-asserted-by":"crossref","first-page":"e170502","DOI":"10.1172\/JCI170502","volume":"133","author":"I Borek","year":"2023","unstructured":"Borek I, Birnhuber A, Voelkel NF, Marsh LM, Kwapiszewska G (2023) The vascular perspective on acute and chronic lung disease. J Clin Invest 133:e170502","journal-title":"J Clin Invest"},{"key":"11653_CR40","doi-asserted-by":"crossref","first-page":"170062","DOI":"10.1183\/16000617.0062-2017","volume":"27","author":"L Plantier","year":"2018","unstructured":"Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B (2018) Physiology of the lung in idiopathic pulmonary fibrosis. Eur Respir Rev 27:170062","journal-title":"Eur Respir Rev"},{"key":"11653_CR41","first-page":"1596","volume":"381","author":"O Distler","year":"2019","unstructured":"Distler O, Gahlemann M, Maher TM (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. Reply. N Engl J Med 381:1596\u20131597","journal-title":"N Engl J Med"},{"key":"11653_CR42","doi-asserted-by":"crossref","first-page":"873709","DOI":"10.3389\/fonc.2022.873709","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Gong X, Hu Y et al (2022) Anti-angiogenic drugs inhibit interstitial lung disease progression in patients with advanced non-small cell lung cancer. Front Oncol 12:873709","journal-title":"Front Oncol"},{"key":"11653_CR43","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.21037\/jtd-24-45","volume":"16","author":"T Yamaguchi","year":"2024","unstructured":"Yamaguchi T, Shimizu J, Shigematsu F et al (2024) Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease. J Thorac Dis 16:3371\u20133380","journal-title":"J Thorac Dis"},{"key":"11653_CR44","doi-asserted-by":"crossref","first-page":"2102058","DOI":"10.1183\/13993003.02058-2021","volume":"60","author":"LA Torres","year":"2022","unstructured":"Torres LA, Lee KE, Barton GP et al (2022) Dynamic contrast enhanced MRI for the evaluation of lung perfusion in idiopathic pulmonary fibrosis. Eur Respir J 60:2102058","journal-title":"Eur Respir J"},{"key":"11653_CR45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jmri.25008","volume":"43","author":"Y Ohno","year":"2016","unstructured":"Ohno Y, Koyama H, Yoshikawa T et al (2016) Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. J Magn Reson Imaging 43:512\u2013532","journal-title":"J Magn Reson Imaging"},{"key":"11653_CR46","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00330-023-10105-4","volume":"34","author":"Y Ohno","year":"2024","unstructured":"Ohno Y, Yui M, Yamamoto K et al (2024) Pulmonary MRI with ultra-short TE using single- and dual-echo methods: comparison of capability for quantitative differentiation of non- or minimally invasive adenocarcinomas from other lung cancers with that of standard-dose thin-section CT. Eur Radiol 34:1065\u20131076","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11653-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:06:35Z","timestamp":1761908795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["11653"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11653-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Yoshiharu Ohno, MD, PhD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Drs. Nagata and Ohno received a research grant from Canon Medical Systems Corporation, which also supported this work financially and technically. Moreover, Dr. Ohno received research grants from the Smoking Research Foundation and a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (JSTS KAKEN No. 20K08037). Y.F., K.F., Y.I., H.K., and N.A. are employees of Canon Medical Systems Corporation. They did not have control over any of the data used in this study. All authors and department chair, Yoshiharu Ohno, who is the first and corresponding author, have agreed to the publication of this study. All data were controlled by Drs. Ohno, Yoshikawa, Seki, Takenaka, Nagata, Nomura, Ueda and Ozawa. Moreover, all statistical analyses were performed by Drs. Yoshikawa, Seki, Takenaka, Nagata, Nomura, Ueda and Ozawa. This information is stated in the main text.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This retrospective study was approved by the Institutional Review Boards of Fujita Health University Hospital and Kobe University Hospital and is compliant with the Health Insurance Portability and Accountability Act.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was not overlapped to any study cohort.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}